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The evolution of imaging technologies over the past decade
has reshaped our landscape in diagnosing and managing
patients with glaucoma. Adopting technological advances
and translating new information into clinical practice pose
newchallengestobothcliniciansandresearchscientists.This
special issue includes ﬁve papers covering some of the recent
advances in ocular imaging and electrophysiology technolo-
gies and demonstrates how such advancement augments our
understanding of glaucoma.
Since its introduction in 2005, the spectral-domain
optical coherence tomography (SD-OCT) has received con-
siderable attention for retinal nerve ﬁber layer (RNFL) and
opticdiscimaging.Withimprovedaxialresolutiontodiscern
individualretinallayers,newparameterssuchastheganglion
cell complex (GCC) and the photoreceptor layer thicknesses
can now be measured reliably with SD-OCT. S. T. Takagi
and et al. demonstrate that macular GCC thickness could
serve as a biomarker for early detection of glaucoma. With
a high density of retinal ganglion cells in the macula, it is
conceivable that measuring macular GCC thickness would
be valuable for glaucoma assessment. By contrast, the outer
retina would be expected to be unaﬀected. Unexpectedly, N.
Fan et al. show that the outer nuclear layer is thicker in mild
glaucomatouseyesthaninnormaleyes.Thisﬁndingsuggests
glaucomatous damage may involve structural change in the
photoreceptors.
Full-ﬁeld electroretinogram (ERG) has been considered
less useful for glaucoma evaluation. S. Machida et al. show
that a photopic negative response (PhNR) (a negative deﬂe-
ction following the photopic b-wave) obtained from a focal
ERG system could indicate functional abnormality of retinal
ganglion cells and has a high diagnostic performance to
detect early glaucoma. While the potential of focal ERG
PhNR for objective functional assessment appears promis-
ing, prospective longitudinal studies are needed to validate
its use in glaucoma patients.
Intraocular pressure (IOP) is a major risk factor for glau-
coma progression. Yet, it has long been recognized that there
arefactorsotherthanIOPthatcouldmodifythecourseofthe
disease. In a randomized double-masked study comparing
dorzolamide/timolol and latanoprost/timolol ﬁxed combi-
nation for treatment in glaucoma patients, I. Januleviˇ ciene
et al. report that a number of hemodynamic parameters
including blood pressure, ocular perfusion pressure, and
ophthalmic and central retinal artery vascular resistance
are associated with RNFL and/or visual ﬁeld progression
independentofIOPreduction.Althoughthisstudyislimited
by a small sample size (15 patients in each arm) and a high
progressionrate(40%and47%ofpatientsprogressed,resp.),
the result could stimulate more research investigating the
roles of ocular and systemic hemodynamics in glaucoma
progression.
Multiphoton microscopy is a relatively new modality
for ophthalmic imaging. E. A. Gibson et al. summarize
the applications of multiphoton microscopy for retinal
and transscleral imaging and demonstrate the feasibility to
visualize the collagen ﬁbers in human trabecular meshwork
ex vivo. The exciting development of multiphoton imaging
will undoubtedly provide new data for potential application
in the clinic in the near future.2 Journal of Ophthalmology
The improvement in patient care depends upon con-
tinued research and development of new tools and new
techniques to unfold the pathobiology of glaucoma for early
diagnosis and treatment. It is suﬃcient to say that glaucoma
imaging forms one of the cornerstones in the advancement
of glaucoma care.
Christopher K. S. Leung
Felipe A. Medeiros
David Garway-Heath
David S. Greenﬁeld
Robert N. Weinreb